新型抗鼻病毒化合物R 61837的体外活性
In vitro activity of R 61837, a new antirhinovirus compound.
作者信息
Andries K, Dewindt B, De Brabander M, Stokbroekx R, Janssen P A
机构信息
Janssen Research Foundation, Beerse, Belgium.
出版信息
Arch Virol. 1988;101(3-4):155-67. doi: 10.1007/BF01310997.
Abstract
R 61837 or 3-methoxy-6-[4-(3-methylphenyl)-1-piperazinyl]pyridazine is a new and potent inhibitor of rhinoviruses at concentrations not inhibitory to HeLa cell growth. Different rhinovirus serotypes varied widely in their susceptibility to the antiviral agent. The MICs for 50% CPE reduction ranged from 0.004 to 15 micrograms/ml. The yields of the most susceptible serotypes were reduced by a factor of 1,000 to 10,000 after single round high multiplicity infections in presence of low concentrations of the compound. The inactivation of some but not all serotypes in a time-, concentration- and temperature-dependent way by R 61837 indicated a direct interaction between the drug and the viral particles. The antiviral activity of the compound was confirmed in the human target cells for rhinoviruses by experiments using nasal polyp explant cultures.
摘要
R 61837或3-甲氧基-6-[4-(3-甲基苯基)-1-哌嗪基]哒嗪是一种新型强效鼻病毒抑制剂，其浓度对HeLa细胞生长无抑制作用。不同的鼻病毒血清型对该抗病毒药物的敏感性差异很大。使50%细胞病变效应减少的最低抑菌浓度范围为0.004至15微克/毫升。在低浓度化合物存在下进行单轮高复数感染后，最敏感血清型的产量降低了1000至10000倍。R 61837以时间、浓度和温度依赖的方式使部分而非全部血清型失活，表明该药物与病毒颗粒之间存在直接相互作用。通过使用鼻息肉外植体培养物的实验，在人鼻病毒靶细胞中证实了该化合物的抗病毒活性。
相似文献
1
In vitro activity of R 61837, a new antirhinovirus compound.新型抗鼻病毒化合物R 61837的体外活性
Arch Virol. 1988;101(3-4):155-67. doi: 10.1007/BF01310997.
2
Lack of quantitative correlation between inhibition of replication of rhinoviruses by an antiviral drug and their stabilization.
Arch Virol. 1989;106(1-2):51-61. doi: 10.1007/BF01311037.
3
In vitro activity of pirodavir (R 77975), a substituted phenoxy-pyridazinamine with broad-spectrum antipicornaviral activity.吡罗达韦（R 77975）的体外活性，一种具有广谱抗微小核糖核酸病毒活性的取代苯氧基哒嗪胺。
Antimicrob Agents Chemother. 1992 Jan;36(1):100-7. doi: 10.1128/AAC.36.1.100.
4
Synthesis and activity of piperazine-containing antirhinoviral agents and crystal structure of SDZ 880-061 bound to human rhinovirus 14.含哌嗪的抗鼻病毒药物的合成与活性以及与14型人鼻病毒结合的SDZ 880-061的晶体结构
J Mol Biol. 1996 May 31;259(1):120-34. doi: 10.1006/jmbi.1996.0307.
5
Direct and specific inactivation of rhinovirus by chalcone Ro 09-0410.查耳酮Ro 09 - 0410对鼻病毒的直接和特异性灭活作用
Antimicrob Agents Chemother. 1982 Oct;22(4):617-21. doi: 10.1128/AAC.22.4.617.
6
In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease.人鼻病毒3C蛋白酶强效抑制剂AG7088的体外抗病毒活性
Antimicrob Agents Chemother. 1999 Oct;43(10):2444-50. doi: 10.1128/AAC.43.10.2444.
7
Studies on 44 081 R.P., a new antirhinovirus compound, in cell cultures and in volunteers.对新型抗鼻病毒化合物44 081 R.P.进行的细胞培养和志愿者研究。
Antimicrob Agents Chemother. 1985 May;27(5):846-50. doi: 10.1128/AAC.27.5.846.
8
SDZ 35-682, a new picornavirus capsid-binding agent with potent antiviral activity.SDZ 35-682，一种具有强大抗病毒活性的新型微小核糖核酸病毒衣壳结合剂。
Antiviral Res. 1995 Jan;26(1):65-82. doi: 10.1016/0166-3542(94)00066-h.
9
Drug resistant rhinoviruses from the nose of experimentally treated volunteers.来自经实验治疗志愿者鼻腔的耐药鼻病毒。
Arch Virol. 1989;109(1-2):71-81. doi: 10.1007/BF01310519.
10
In vitro characterisation of a pleconaril/pirodavir-like compound with potent activity against rhinoviruses.一种对鼻病毒具有强效活性的普来可那立/吡罗达韦样化合物的体外特性研究
Virol J. 2015 Jul 14;12:106. doi: 10.1186/s12985-015-0330-4.
引用本文的文献
1
The pyridazine heterocycle in molecular recognition and drug discovery.哒嗪杂环在分子识别与药物发现中的应用
Med Chem Res. 2023 Mar 15:1-69. doi: 10.1007/s00044-023-03035-9.
2
Targeting the Virus Capsid as a Tool to Fight RNA Viruses.靶向病毒衣壳作为抗击 RNA 病毒的工具。
Viruses. 2022 Jan 18;14(2):174. doi: 10.3390/v14020174.
3
Back to the future: Advances in development of broad-spectrum capsid-binding inhibitors of enteroviruses.回到未来：广谱肠道病毒衣壳结合抑制剂的研发进展。
Eur J Med Chem. 2019 Sep 15;178:606-622. doi: 10.1016/j.ejmech.2019.06.008. Epub 2019 Jun 11.
4
Anti-infective immunoadhesins from plants.植物来源抗感染免疫黏附素。
Plant Biotechnol J. 2015 Oct;13(8):1078-93. doi: 10.1111/pbi.12441. Epub 2015 Aug 4.
5
Infection and propagation of human rhinovirus C in human airway epithelial cells.人鼻病毒 C 在人呼吸道上皮细胞中的感染和传播。
J Virol. 2012 Dec;86(24):13524-32. doi: 10.1128/JVI.02094-12. Epub 2012 Oct 3.
6
The human rhinovirus: human-pathological impact, mechanisms of antirhinoviral agents, and strategies for their discovery.人类鼻病毒：对人类的病理影响、抗鼻病毒药物的作用机制及研发策略。
Med Res Rev. 2011 Jan;31(1):42-92. doi: 10.1002/med.20176.
7
SCH 48973: a potent, broad-spectrum, antienterovirus compound.SCH 48973：一种强效、广谱的抗肠道病毒化合物。
Antimicrob Agents Chemother. 1997 Jun;41(6):1220-5. doi: 10.1128/AAC.41.6.1220.
8
Discrepancy between infectivity and antigenicity stabilization of oral poliovirus vaccine by a capsid-binding compound.衣壳结合化合物对口服脊髓灰质炎疫苗感染性和抗原性稳定性的差异
J Virol. 1994 May;68(5):3397-400. doi: 10.1128/JVI.68.5.3397-3400.1994.
9
In vitro selection of human rhinovirus relatively resistant to soluble intercellular adhesion molecule-1.
Antimicrob Agents Chemother. 1994 Jan;38(1):66-70. doi: 10.1128/AAC.38.1.66.
10
Thermal inactivation of oral polio vaccine: contribution of RNA and protein inactivation.口服脊髓灰质炎疫苗的热灭活：RNA和蛋白质灭活的作用
J Virol. 1994 Oct;68(10):6454-7. doi: 10.1128/JVI.68.10.6454-6457.1994.
本文引用的文献
1
Clonal growth of normal adult human bronchial epithelial cells in a serum-free medium.正常成人支气管上皮细胞在无血清培养基中的克隆生长。
In Vitro. 1982 Jul;18(7):633-42. doi: 10.1007/BF02796396.
2
Failure of oral 4',6-dichloroflavan to protect against rhinovirus infection in man.口服4',6-二氯黄烷对人体鼻病毒感染无预防作用。
Arch Virol. 1983;75(1-2):115-21. doi: 10.1007/BF01314131.
3
Direct and specific inactivation of rhinovirus by chalcone Ro 09-0410.查耳酮Ro 09 - 0410对鼻病毒的直接和特异性灭活作用
Antimicrob Agents Chemother. 1982 Oct;22(4):617-21. doi: 10.1128/AAC.22.4.617.
4
4',6-Dichloroflavan (BW683C), a new anti-rhinovirus compound.4',6-二氯黄烷（BW683C），一种新型抗鼻病毒化合物。
Nature. 1981 Jul 23;292(5821):369-70. doi: 10.1038/292369a0.
5
The common cold: control?普通感冒：可控吗？
J Infect Dis. 1984 Aug;150(2):167-73. doi: 10.1093/infdis/150.2.167.
6
Evaluation of the antirhinovirus chalcone Ro 09-0415 given orally to volunteers.对口服给志愿者的抗鼻病毒查耳酮Ro 09 - 0415的评估。
J Antimicrob Chemother. 1984 Oct;14(4):403-9. doi: 10.1093/jac/14.4.403.
7
Effect of dichloroflavan (BW683C) on the stability and uncoating of rhinovirus type 1B.
J Antimicrob Chemother. 1984 Aug;14 Suppl A:97-105. doi: 10.1093/jac/14.suppl_a.97.
8
Growth requirements of ferret tracheal epithelial cells in primary culture.
Proc Soc Exp Biol Med. 1985 Jul;179(3):309-17. doi: 10.3181/00379727-179-42102.
9
In vitro antiviral activity of the 6-substituted 2-(3',4'-dichlorophenoxy)-2H-pyrano[2,3-b]pyridines MDL 20,610, MDL 20,646, and MDL 20,957.6-取代的2-(3',4'-二氯苯氧基)-2H-吡喃并[2,3-b]吡啶MDL 20,610、MDL 20,646和MDL 20,957的体外抗病毒活性
Antimicrob Agents Chemother. 1986 Sep;30(3):516-8. doi: 10.1128/AAC.30.3.516.
10
Failure of intranasally administered 4', 6-dichloroflavan to protect against rhinovirus infection in man.经鼻给予4',6-二氯黄烷未能预防人鼻病毒感染。
Arch Virol. 1987;92(3-4):255-60. doi: 10.1007/BF01317482.
Zotero 插件